The artificial intelligence (AI) software Saige-Density™ reportedly provides automated assessment of breast density during mammography exams.
In light of a pending national standard requiring breast density notification in mammography reports, an emerging artificial intelligence (AI) tool may help reduce subjectivity and variability in breast density assessments.
The Food and Drug Administration (FDA) has granted 510(k) clearance for Saige-Density™ (DeepHealth/RadNet), an adjunctive AI software that provides automated categorization of breast density based on the American College of Radiology’s Breast Imaging Reporting and Data System (BI-RADS) classification.
DeepHealth said a retrospective, multicenter study showed a 91.5 percent alignment between Saige-Density assessment and consensus assessment of breast density by five specialists in breast imaging. The Saige-Density AI algorithm was trained on a racially diverse database of over 166,000 images from 30,000 mammography exams across the United States, according to DeepHealth.
(Editor’s note: For related content, see “Mammography News: FDA Says National Breast Density Notification Rule May Be Published in Late 2022 or Early 2003,” “Can AI Improve the Consistency of Breast Density Assessment by Radiologists?” and “Current Insights on Breast Density, Contrast-Enhanced Mammography and Supplemental Breast Cancer Screening.”)
“Achieving FDA clearance for another important tool in the breast cancer screening process in such a short time frame highlights our aggressive commitment to bringing state-of-the art AI innovation to the breast screening mammography market,” noted Gregory Sorenson, M.D., the CEO and co-founder of DeepHealth. “We have developed another one of the most advanced AI algorithms to date to support radiologists in their fight to find breast cancer as early as possible.”
DeepHealth previously received FDA 510(k) clearances for the AI mammography triage software Saige-Q and the adjunctive diagnostic mammography software Saige-Dx.
References
1. RadNet. RadNet’s artificial intelligence subsidiary, DeepHealth, announces FDA clearance of its third AI mammography product. GlobeNewswire. Available at: https://www.globenewswire.com/news-release/2022/12/19/2576071/10985/en/RadNet-s-Artificial-Intelligence-Subsidiary-DeepHealth-Announces-FDA-Clearance-of-its-Third-AI-Mammography-Product.html . Published December 19, 2022. Accessed December 19, 2022.
2. DeepHealth. Saige-Density mammography density assessment software. Available at: https://deep.health/products/saige-density/ . Accessed December 19, 2022.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.